toxylact: a06ag02 bisacodyl

The first professional lActological database in the word

Bisacodyl (ATC A06AG02) is a stimulant laxative used mainly for short‑term relief of constipation and bowel preparation, and it is considered compatible with breastfeeding because its active moiety is not excreted into human milk in measurable amounts.ncbi.nlm.nih+3

Pharmacological class and mechanism

Bisacodyl is a contact (stimulant) laxative belonging to ATC class A06AG02, rectal preparations for constipation (enemas and suppositories). It acts locally in the colon by directly stimulating enteric nerves, increasing peristalsis and promoting colonic evacuation. It may also increase water content in the stool, which facilitates defecation.medpedia.framar+3

Indications and clinical use

Medicines in class A06AG02 (bisacodyl rectal preparations) are indicated for short‑term symptomatic treatment of constipation and for bowel cleansing before diagnostic procedures or surgery. Use is generally recommended for brief courses only, often as part of bowel preparation protocols or when oral laxatives are not suitable.medicalguidelines.msf+4

Contraindications and cautions

Rectal bisacodyl should not be used in patients with known hypersensitivity to bisacodyl or excipients, acute surgical abdomen, gastrointestinal bleeding or intestinal neoplasms. It is usually avoided in pregnancy in favor of better‑studied alternatives, and stimulant laxatives are not first‑line for chronic constipation.nhs+4

Adverse effects and toxicity

Typical adverse reactions are abdominal pain, cramping, diarrhea and increased mucus production in the stool. Excessive or prolonged use may lead to electrolyte disturbances, dehydration or dependence on laxatives, so all bisacodyl formulations are recommended only for short‑term use.berkoilac+3

Lactation toxicology

Pharmacokinetics in lactation
Bisacodyl itself is poorly absorbed from the gastrointestinal tract; its active metabolite, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), is systemically absorbed but studies show no excretion into human breast milk after single or multiple doses of oral tablets or rectal suppositories. In a study of postpartum women, BHPM levels remained below the limits of detection in breast milk, suggesting negligible infant exposure.pubmed.ncbi.nlm.nih+2

Evidence and expert assessments
Authoritative lactation sources state that bisacodyl can be taken during breastfeeding and that no special precautions are required because the active metabolite is not detectable in milk. National and specialist guidance on laxatives in breastfeeding concludes that bisacodyl may be used during lactation, with recommendations generally applying to healthy, full‑term infants. Consumer‑facing guidance (NHS and others) similarly notes that bisacodyl is not thought to pass into breast milk and is unlikely to cause adverse effects in breastfed infants.drugs+4

Infant risk and monitoring
Given the lack of measurable drug in milk and the low oral bioavailability to the infant, clinically relevant exposure through breastfeeding is expected to be minimal. Routine monitoring of the breastfed infant is not required, though observation for unusual diarrhea or irritability is reasonable when any stimulant laxative is used.sps+5

Preferred use pattern in breastfeeding
In breastfeeding women with constipation, osmotic or bulk‑forming laxatives are typically considered first‑line, especially for persistent symptoms. However, when a stimulant laxative is needed or rectal administration is preferred—for example, peri‑procedurally—bisacodyl rectal preparations (A06AG02) are considered suitable and compatible with breastfeeding when used at recommended doses and for the shortest necessary duration.breastfeedingnetwork+4

Regulatory and practical aspects

Bisacodyl rectal products are widely available, often without prescription, for self‑management of occasional constipation. Professional guidelines emphasize short‑term use, attention to underlying causes of constipation, and prioritizing dietary measures and non‑stimulant laxatives before stimulant agents in breastfeeding women.webmd+4

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.